{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:17:13Z","timestamp":1777555033251,"version":"3.51.4"},"reference-count":12,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Dermatitis\u00ae"],"published-print":{"date-parts":[[2014,4,1]]},"abstract":"Abstrct<\/jats:title>\n \n Toxicology endeavors to predict the potential of materials to cause adverse health (and environmental) effects and to assess the risk(s) associated with exposure. For skin sensitizers, the local lymph node assay was the first method to be fully and independently validated, as well as the first to offer an objective end point with a quantitative measure of sensitizing potency (in addition to hazard identification). Fifteen years later, it serves as the primary standard for the development of in vitro\/\n in chemico<\/jats:italic>\n \/\n in silico<\/jats:italic>\n alternatives.\n <\/jats:p>","DOI":"10.1097\/der.0000000000000024","type":"journal-article","created":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T12:01:15Z","timestamp":1397649675000},"page":"49-50","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["The Local Lymph Node Assay in 2014"],"prefix":"10.1177","volume":"25","author":[{"given":"David A.","family":"Basketter","sequence":"first","affiliation":[{"name":"From *DABMEB Consultancy Ltd, Sharnbrook, Bedfordshire, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Frank","family":"Gerberick","sequence":"additional","affiliation":[{"name":"Procter & Gamble, Mason, Cincinnati, OH;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Kimber","sequence":"additional","affiliation":[{"name":"Faculty of Life Sciences, University of Manchester, Manchester, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2014,4,1]]},"reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2133.2008.08625.x","article-title":"Skin sensitisation: strategies for risk assessment and risk management","volume":"159","author":"Basketter DA","year":"2008","unstructured":"Basketter DA. Skin sensitisation: strategies for risk assessment and risk management. Br J Dermatol, 2008; 159: 267\u2013273.","journal-title":"Br J Dermatol"},{"key":"e_1_3_1_3_2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0278-6915(92)90153-C","article-title":"The murine local lymph node assay; collaborative studies and new directions: a commentary","volume":"30","author":"Kimber I","year":"1992","unstructured":"Kimber I, , Basketter DA. The murine local lymph node assay; collaborative studies and new directions: a commentary. Food Chem Toxicol, 1992; 30: 165\u2013169.","journal-title":"Food Chem Toxicol"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajcd.2000.2946"},{"key":"e_1_3_1_5_2","unstructured":"Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) Report. The murine local lymph node assay: a test method for assessing the allergic contact dermatitis potential of chemicals\/compounds. NIH Publication No. 99-4494. 1999."},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2007.01141.x"},{"key":"e_1_3_1_7_2","first-page":"156","article-title":"Contact allergenic potency: correlation of human and local lymph node assay data","volume":"12","author":"Gerberick GF","year":"2001","unstructured":"Gerberick GF, , Robinson MK, , Ryan CA, et al. Contact allergenic potency: correlation of human and local lymph node assay data. Am J Contact Dermat, 2001; 12: 156\u2013161.","journal-title":"Am J Contact Dermat"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2008.01.010"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2000.042005251.x"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2007.10.008"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/01206501-200512000-00002"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.2310\/6620.2009.09038"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000003"}],"container-title":["Dermatitis\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1097\/DER.0000000000000024","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1097\/DER.0000000000000024","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1097\/DER.0000000000000024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:08:20Z","timestamp":1777399700000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1097\/DER.0000000000000024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,1]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4,1]]}},"alternative-id":["10.1097\/DER.0000000000000024"],"URL":"https:\/\/doi.org\/10.1097\/der.0000000000000024","relation":{},"ISSN":["1710-3568","2162-5220"],"issn-type":[{"value":"1710-3568","type":"print"},{"value":"2162-5220","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,1]]}}}